BRPI0924286A2 - detecção de produtos de degradação dafibrina e fibrinogênio e métodos associados de produção e uso para a detecção e monitoramento de câncer - Google Patents

detecção de produtos de degradação dafibrina e fibrinogênio e métodos associados de produção e uso para a detecção e monitoramento de câncer

Info

Publication number
BRPI0924286A2
BRPI0924286A2 BRPI0924286A BRPI0924286A BRPI0924286A2 BR PI0924286 A2 BRPI0924286 A2 BR PI0924286A2 BR PI0924286 A BRPI0924286 A BR PI0924286A BR PI0924286 A BRPI0924286 A BR PI0924286A BR PI0924286 A2 BRPI0924286 A2 BR PI0924286A2
Authority
BR
Brazil
Prior art keywords
detection
fibrinogen
monitoring
production
degradation products
Prior art date
Application number
BRPI0924286A
Other languages
English (en)
Portuguese (pt)
Inventor
Andrea Small-Howard
Original Assignee
Amdl Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amdl Inc filed Critical Amdl Inc
Publication of BRPI0924286A2 publication Critical patent/BRPI0924286A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
BRPI0924286A 2009-03-30 2009-03-30 detecção de produtos de degradação dafibrina e fibrinogênio e métodos associados de produção e uso para a detecção e monitoramento de câncer BRPI0924286A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2009/038833 WO2010114514A1 (fr) 2009-03-30 2009-03-30 Détection de produits de dégradation de fibrine et de fibrinogène, et procédés connexes de production et d'utilisation pour la détection et la surveillance d'un cancer

Publications (1)

Publication Number Publication Date
BRPI0924286A2 true BRPI0924286A2 (pt) 2016-01-26

Family

ID=41278698

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0924286A BRPI0924286A2 (pt) 2009-03-30 2009-03-30 detecção de produtos de degradação dafibrina e fibrinogênio e métodos associados de produção e uso para a detecção e monitoramento de câncer

Country Status (9)

Country Link
EP (1) EP2414843A1 (fr)
JP (1) JP2012522246A (fr)
KR (1) KR20120057562A (fr)
CN (1) CN102405413A (fr)
AU (1) AU2009343805A1 (fr)
BR (1) BRPI0924286A2 (fr)
CA (1) CA2755486A1 (fr)
RU (1) RU2011143747A (fr)
WO (1) WO2010114514A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014513949A (ja) * 2011-04-20 2014-06-19 トラクソン・リミテッド・ライアビリティ・カンパニー 患者における癌の診断方法
CA2847839A1 (fr) 2011-09-07 2013-03-14 Genway Biotech, Inc. Dosage de diagnostic pour la prediction d'un risque cardiovasculaire
WO2015006713A1 (fr) 2013-07-12 2015-01-15 Emory University Dosage de diagnostic pour la prédiction d'un risque cardiovasculaire
CN103954758A (zh) * 2014-05-15 2014-07-30 海南世济医学技术有限公司 一种用于纤维蛋白和纤维蛋白原及其降解产物的检测方法和试剂盒
CN104062436B (zh) * 2014-06-06 2016-02-10 上海良润生物医药科技有限公司 Fxyd在制备诊断和预示肺癌标志物中的应用及fxyd双抗夹心elisa检测试剂盒
GB201518466D0 (en) * 2015-10-19 2015-12-02 Cizzle Biotechnology Ltd Use
RU2742279C2 (ru) * 2016-02-22 2021-02-04 ЭлЭсАй МЕДИЕНС КОРПОРЕЙШН Реагент для оценки продукта расщепления перекрестносшитого фибрина и способ такой оценки
JP6667380B2 (ja) * 2016-06-17 2020-03-18 シスメックス株式会社 血液分析のための方法、血液分析装置、コンピュータプログラム、キャリブレータセット、及びキャリブレータセットの作製方法
CN106680482A (zh) * 2016-12-23 2017-05-17 上海良润生物医药科技有限公司 尿液fxyd检测试剂盒
TW202313954A (zh) * 2021-09-28 2023-04-01 華宇藥品股份有限公司 同伴動物的生物標記偵測方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7713498A (en) * 1997-06-03 1998-12-21 Amdl, Inc. Immunoassay for the detection of cancer
US20040033544A1 (en) * 2000-03-07 2004-02-19 Ngo That T. Polyclonal antibodies against fibrinogen degradation products and associated methods of production and use

Also Published As

Publication number Publication date
CA2755486A1 (fr) 2010-10-07
WO2010114514A1 (fr) 2010-10-07
RU2011143747A (ru) 2013-05-10
JP2012522246A (ja) 2012-09-20
CN102405413A (zh) 2012-04-04
EP2414843A1 (fr) 2012-02-08
AU2009343805A1 (en) 2011-09-29
KR20120057562A (ko) 2012-06-05

Similar Documents

Publication Publication Date Title
BRPI0924286A2 (pt) detecção de produtos de degradação dafibrina e fibrinogênio e métodos associados de produção e uso para a detecção e monitoramento de câncer
BR112013013888A2 (pt) sistemas e métodos para monitoramento de poço
BR112014000766A2 (pt) método para fabricação de a esteira de sensibilidade de pressão; e método para testar uma esteira de sensibilidade de pressão
FI20105606A (fi) Hiomatuote ja menetelmä tällaisen valmistamiseksi
IT1395537B1 (it) Metodo di monitoraggio
BR112012003745A2 (pt) métodos e produtos para iluminação de tecidos
ES2685958T8 (es) Procedimiento para la detección temprana de trenes
BR112013007506A2 (pt) piridinonas/pirazinonas - métodos de criação e de uso
BRPI1106096A2 (pt) dispositivo de monitoramento de material analítico e métodos.
EE200900072A (et) Territooriumi ja selle perimeetri jälgimise süsteem ja meetod
EP2486233A4 (fr) Planification et surveillance d'essai des couches
BR112013014442A2 (pt) micro-organismos para a produção de putrescina e método para a produção de putrescina utilizando o mesmo
BR112013014468A2 (pt) pneu inflável e método para sua produção
BRPI1010619A2 (pt) biomaterial multidimensional e método para sua produção
FI20090142A0 (fi) Uudet menetelmät ja tuotteet
BR112012032494A2 (pt) produto, utilizaçõa e método de produção de um produto
BR112013006131A2 (pt) inibidores de notum pectinacetilesterase e métodos para sua utilização
BRPI0722175A8 (pt) método e aparelho para monitorar a formação de coágulo de fibrina espacial
BR112013029317A2 (pt) dispositivo e método para medir a extensão de uma corrente, revolvente continuamente do dispositivo
BRPI1011584A2 (pt) método e sistema para monitoramento de produtividade associada a uma máquina
BR112013014830A2 (pt) monitoramento de cavidade
BR112012019275A2 (pt) processos de produção de estireno e catalisadores para uso neles
FI20095500A0 (fi) Tuote ja menetelmä sen valmistamiseksi
EE05616B1 (et) Meetod ja seade sageduskarakteristiku m??tmiseks
BRPI0910426A2 (pt) Solução de delta-9-thc e método para sua produção

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08G Application fees: restoration [chapter 8.7 patent gazette]
B08F Application fees: application dismissed [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]